Newomics, Inc.

Emeryville, CA 94608

SBIR Award Summary

Total Number of Awards 16
Total Value of Awards $7.1MM
First Award Date 09/20/12
Most Recent Award Date 05/26/17

Key Personnel

Last Name Name Awards Contact
Mao Pan Mao 1
Wang Daojing Wang 15

16 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-ES-15-006
Budget: 05/26/17 - 01/31/18

? DESCRIPTION (provided by applicant): There is a paradigm shift in testing and modeling of chemical toxicity. Current toxicology calls for cell-based (vs. animal-based), evidence-based, and Omics-based assays. Mesenchymal stem cells (MSC) play important roles in the maintenance and repair of various tissues, including bone, cartilage, and mu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AT-16-003
Budget: 05/01/17 - 04/30/18

? DESCRIPTION (provided by applicant): Natural products are rich sources for potential drugs. To accelerate drug discovery from natural products, it is imperative to identify their molecular targets, and mechanistically elucidate their bioavailability, toxicity, and therapeutic effects. However, there remain several challenges in the field. A...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-ES-15-006
Budget: 02/01/17 - 01/31/18

? DESCRIPTION (provided by applicant): There is a paradigm shift in testing and modeling of chemical toxicity. Current toxicology calls for cell-based (vs. animal-based), evidence-based, and Omics-based assays. Mesenchymal stem cells (MSC) play important roles in the maintenance and repair of various tissues, including bone, cartilage, and mu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AT-16-003
Budget: 05/01/16 - 04/30/17

? DESCRIPTION (provided by applicant): Natural products are rich sources for potential drugs. To accelerate drug discovery from natural products, it is imperative to identify their molecular targets, and mechanistically elucidate their bioavailability, toxicity, and therapeutic effects. However, there remain several challenges in the field. Am...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-RF-AE-005
Budget: 03/01/16 - 02/28/17

? DESCRIPTION (provided by applicant): One of the most exciting developments in environmental science and technology is the emerging field of exposomics, i.e., rapid and sensitive detection of large sets of analytes (exposome) reflecting the complexity of exposure in the personal environment using human specimens including blood, urine, and s...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-ES-15-006
Budget: 02/01/16 - 01/31/17

? DESCRIPTION (provided by applicant): There is a paradigm shift in testing and modeling of chemical toxicity. Current toxicology calls for cell-based (vs. animal-based), evidence-based, and Omics-based assays. Mesenchymal stem cells (MSC) play important roles in the maintenance and repair of various tissues, including bone, cartilage, and mu...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-044
Budget: 08/01/15 - 07/31/16

DESCRIPTION (provided by applicant): Ideal biomarkers of acute and delayed radiation injury after a radiological/nuclear terrorist incident are those that arise and are measurable prio to manifestation of tissue injuries, typically one to a few days after ionizing radiation (IR) exposure. They should also be measurable in a non-invasive or mini...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-215
Budget: 05/01/15 - 04/30/16

DESCRIPTION (provided by applicant): The proteome reflects the physiology and pathology states of a patient therefore proteomics is a powerful tool for early diagnostics of diseases and monitoring of therapeutic responses. Mass spectrometry (MS) measures the mass-to-charge ratio of charged species and has become the enabling technology for prote...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 05/01/15 - 04/30/16

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a devastating neurodegenerative disease that affects more than 35 million people (including 5 million Americans) worldwide, and this number is expected to reach more than 115 million by the year 2050. Recent disappointing clinical trials of bapineuzumab and solanezumab in AD treatm...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-ES-14-005
Budget: 03/13/15 - 02/29/16

DESCRIPTION (provided by applicant): One of the most exciting developments in environmental science and technology is the emerging field of "exposomics", i.e., rapid and sensitive detection of large sets of analytes ("exposome") reflecting the complexity of exposure in the personal environment using human specimens including blood, urine, and sa...

Load More